Cystine growth inhibition through molecular mimicry

A new paradigm for the prevention of crystal diseases

Michael H. Lee, Amrik Sahota, Michael Ward, David S. Goldfarb

Research output: Contribution to journalArticle

Abstract

Cystinuria is a genetic disease marked by recurrent kidney stone formation, usually at a young age. It frequently leads to chronic kidney disease. Treatment options for cystinuria have been limited despite comprehensive understanding of its genetic pathophysiology. Currently available therapies suffer from either poor clinical adherence to the regimen or potentially serious adverse effects. Recently, we employed atomic force miscopy (AFM) to identify l-cystine dimethylester (CDME) as an effective molecular imposter of l-cystine, capable of inhibiting crystal growth in vitro. More recently, we demonstrated CDME’s efficacy in inhibiting l-cystine crystal growth in vivo utilizing a murine model of cystinuria. The application of AFM to discover inhibitors of crystal growth through structural mimicry suggests a novel approach to preventing and treating crystal diseases.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalCurrent Rheumatology Reports
Volume17
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Cystinuria
Molecular Mimicry
Cystine
Crystallization
Growth
Inborn Genetic Diseases
Kidney Calculi
Chronic Renal Insufficiency
Therapeutics

Keywords

  • Atomic force microscopy
  • Cystinuria
  • Kidney stones
  • L-cystine
  • L-cystine dimethylester
  • L-cystine methylester
  • Molecular imposter

ASJC Scopus subject areas

  • Rheumatology

Cite this

Cystine growth inhibition through molecular mimicry : A new paradigm for the prevention of crystal diseases. / Lee, Michael H.; Sahota, Amrik; Ward, Michael; Goldfarb, David S.

In: Current Rheumatology Reports, Vol. 17, No. 5, 01.05.2015, p. 1-6.

Research output: Contribution to journalArticle

@article{b479fd0b640b4944a2fbce52e57405f1,
title = "Cystine growth inhibition through molecular mimicry: A new paradigm for the prevention of crystal diseases",
abstract = "Cystinuria is a genetic disease marked by recurrent kidney stone formation, usually at a young age. It frequently leads to chronic kidney disease. Treatment options for cystinuria have been limited despite comprehensive understanding of its genetic pathophysiology. Currently available therapies suffer from either poor clinical adherence to the regimen or potentially serious adverse effects. Recently, we employed atomic force miscopy (AFM) to identify l-cystine dimethylester (CDME) as an effective molecular imposter of l-cystine, capable of inhibiting crystal growth in vitro. More recently, we demonstrated CDME’s efficacy in inhibiting l-cystine crystal growth in vivo utilizing a murine model of cystinuria. The application of AFM to discover inhibitors of crystal growth through structural mimicry suggests a novel approach to preventing and treating crystal diseases.",
keywords = "Atomic force microscopy, Cystinuria, Kidney stones, L-cystine, L-cystine dimethylester, L-cystine methylester, Molecular imposter",
author = "Lee, {Michael H.} and Amrik Sahota and Michael Ward and Goldfarb, {David S.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1007/s11926-015-0510-7",
language = "English (US)",
volume = "17",
pages = "1--6",
journal = "Current Rheumatology Reports",
issn = "1523-3774",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Cystine growth inhibition through molecular mimicry

T2 - A new paradigm for the prevention of crystal diseases

AU - Lee, Michael H.

AU - Sahota, Amrik

AU - Ward, Michael

AU - Goldfarb, David S.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Cystinuria is a genetic disease marked by recurrent kidney stone formation, usually at a young age. It frequently leads to chronic kidney disease. Treatment options for cystinuria have been limited despite comprehensive understanding of its genetic pathophysiology. Currently available therapies suffer from either poor clinical adherence to the regimen or potentially serious adverse effects. Recently, we employed atomic force miscopy (AFM) to identify l-cystine dimethylester (CDME) as an effective molecular imposter of l-cystine, capable of inhibiting crystal growth in vitro. More recently, we demonstrated CDME’s efficacy in inhibiting l-cystine crystal growth in vivo utilizing a murine model of cystinuria. The application of AFM to discover inhibitors of crystal growth through structural mimicry suggests a novel approach to preventing and treating crystal diseases.

AB - Cystinuria is a genetic disease marked by recurrent kidney stone formation, usually at a young age. It frequently leads to chronic kidney disease. Treatment options for cystinuria have been limited despite comprehensive understanding of its genetic pathophysiology. Currently available therapies suffer from either poor clinical adherence to the regimen or potentially serious adverse effects. Recently, we employed atomic force miscopy (AFM) to identify l-cystine dimethylester (CDME) as an effective molecular imposter of l-cystine, capable of inhibiting crystal growth in vitro. More recently, we demonstrated CDME’s efficacy in inhibiting l-cystine crystal growth in vivo utilizing a murine model of cystinuria. The application of AFM to discover inhibitors of crystal growth through structural mimicry suggests a novel approach to preventing and treating crystal diseases.

KW - Atomic force microscopy

KW - Cystinuria

KW - Kidney stones

KW - L-cystine

KW - L-cystine dimethylester

KW - L-cystine methylester

KW - Molecular imposter

UR - http://www.scopus.com/inward/record.url?scp=84928343949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928343949&partnerID=8YFLogxK

U2 - 10.1007/s11926-015-0510-7

DO - 10.1007/s11926-015-0510-7

M3 - Article

VL - 17

SP - 1

EP - 6

JO - Current Rheumatology Reports

JF - Current Rheumatology Reports

SN - 1523-3774

IS - 5

ER -